ClinicalTrials.Veeva

Menu

Russian Disc Degeneration Study (RuDDS)

N

Novosibirsk State University

Status

Completed

Conditions

Intervertebral Disc Degeneration
Genetic Predisposition to Disease

Treatments

Other: Non-interventional

Study type

Observational

Funder types

Other

Identifiers

NCT04600544
NS02-04

Details and patient eligibility

About

The main aim of this study is to establish disease-oriented biobank to facilitate research in biology of the lumbar disc degeneration. Diverse biological samples (whole blood, plasma, disc tissue) along with MRI imaging, clinical, socio-demographic and various omics data (e.g. genomic and transcriptomic) will be available for researchers and clinicians for a variety of further multi-omics studies. It will lay the groundwork for the development of early diagnostics of DDD and its personalized treatment.

The study is planned to enroll up to 1,100 patients with different grades of lumbar disc degeneration. It is planned to recruit patients within 36 months.

Enrollment

1,070 patients

Sex

All

Ages

18 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age over 18;
  2. Presence of lumbar MRI scans;
  3. Signed informed consent for voluntary participation is provided.

Exclusion criteria

  1. Any contraindication or inability to undergo baseline procedures;
  2. Prior surgeries at any level of the lumbar spine;
  3. Other non-degenerative spinal conditions that may have an impact on subject safety, wellbeing or the intent and conduction of the study;
  4. History or presence of HIV, hepatitis B, hepatitis C.

Trial contacts and locations

3

Loading...

Central trial contact

Olga Leonova, PhD, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems